Abstract:Cancer remains a primary threat to human lives. Recently, amplification of tumor-associated reactive oxygen species (ROS) has been used as a boosting strategy to improve tumor therapy. Here, we report on a bone-targeting prodrug mesoporous silica-based nanoreactor for combined photodynamic therapy (PDT) and enhanced chemotherapy for osteosarcoma. Because of surface modification of a bone-targeting biphosphate moiety and the enhanced permeability and retention effect, the formed nanoreactor shows efficient accumulation in osteosarcoma and exhibits long-term retention in the tumor microenvironment. Upon laser irradiation, the loaded photosensitizer chlorin e6 (Ce6) produces in situ ROS, which not only works for PDT but also functions as a trigger for controlled release of doxorubicin (DOX) and doxycycline (DOXY) from the prodrugs based on a thioketal (<i>TK</i>) linkage. The released DOXY further promotes ROS production, thus perpetuating subsequent DOX/DOXY release and ROS burst. The ROS amplification induces long-term high oxidative stress, which increases the sensitivity of the osteosarcoma to chemotherapy, therefore resulting in enhanced tumor cell inhibition and apoptosis. The as-developed nanoreactor with combined PDT and enhanced chemotherapy based on ROS amplification shows significant promise as a potential platform for cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c08992?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c08992</a>.1H NMR spectra of TK, DOX-TK, and DOX-TK-DOXY; inverted fluorescence microscopy images and cell apoptosis with TUNEL staining and cell cycle analyses of OS-732 cells; loading contents of Ce6 for /MSN/DOX-TK-DOXY; particle size, UV-vis absorption spectra, and DOX and DOXY release profiles of /MSN/DOX-TK-DOXY; phototriggered intracellular DOX and DOXY release; intracellular ROS production in OS-732 cells; cell apoptosis with TUNEL staining of OS-732 cells treated with /MSN/DOX-TK-DOXY; MTP measurements for /MSN/DOX-TK-DOX; OS-732 cell metabolism after different treatments; body weights of mice bearing OS-732 tumors; ROS analysis in tumor tissues after treatment with /MSN/DOX-TK-DOXY; inner ring tumor microvessel tortuosity and density; HE staining of main organs after treatment; CD31 expression and RT-PCR analyses of tumor vessels; and quantification of DOX and DOXY contents in major organs (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c08992/suppl_file/am0c08992_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Local delivery of sunitinib and Ce6<i>via</i>redox-responsive zwitterionic hydrogels effectively prevents osteosarcoma recurrence

Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy

Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment

Peritumoral Microgel Reservoir for Long-Term Light-Controlled Triple-Synergistic Treatment of Osteosarcoma with Single Ultra-Low Dose.

Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR-Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA

PLK1shRNA and Doxorubicin Co-Loaded Thermosensitive PLGA-PEG-PLGA Hydrogels for Osteosarcoma Treatment

Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.

Oligopeptide modified ICG/Cisplatin@CaCO 3 for targeted osteosarcoma NIR-II imaging guided multimodal therapy

Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo

Reduction-responsive Polypeptide Nanomedicines Significantly Inhibit Progression of Orthotopic Osteosarcoma.

Thermo-sensitive hydrogel-mediated Locally sequential release of doxorubicin and Palbociclib for chemo-immunotherapy of osteosarcoma

Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment

Hyaluronate-Based Self-Stabilized Nanoparticles for Immunosuppression Reversion and Immunochemotherapy in Osteosarcoma Treatment

CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma

Alginate/chitosan-based hemostatic microspheres loaded with doxorubicin liposomes for postoperative local drug delivery in solid tumor

Recent advances in nanoagents delivery system-based phototherapy for osteosarcoma treatment

Implantable Bioresponsive Hydrogel Prevents Local Recurrence of Breast Cancer by Enhancing Radiosensitivity

Injectable Hydrogel-Microsphere Construct with Sequential Degradation for Locally Synergistic Chemotherapy

Reversing the pathological microenvironment by radiocatalytic sensitizer for local orthotopic osteosarcoma radiotherapy enhancement

Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma